Study guide
8.4 Nonprescription, Behind-the-Counter & Restricted OTC Products
Massachusetts MPJE Pharmacy Jurisprudence Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Federal Drug Law & Regulatory Foundations
1.1 Federal Acts & Agencies 1.2 Drug Supply Chain Security & Adulteration/Misbranding 1.3 Poison Prevention & Special Packaging Standards
2 Chapter 2: Federal Controlled Substances Act (CSA) Governance
2.1 CSA Scheduling, Registration & Ordering 2.2 Controlled Substance Inventory, Theft & Disposal 2.3 Corresponding Responsibility & DEA Red Flags
3 Chapter 3: Massachusetts Board Authority, Licensure & Continuing Education
3.1 Board of Registration in Pharmacy: Structure & Enforcement 3.2 Pharmacist Licensure, Reciprocity & Renewal 3.3 Continuing Education Requirements
4 Chapter 4: Massachusetts Pharmacy Personnel & Supervision
4.1 Pharmacy Interns: Licensure, Hours & Preceptors 4.2 Pharmacy Technician Licensure Tiers & Scope 4.3 Supervisory Ratios & Direct Supervision 4.4 Manager of Record: Duties, Appointment & Reporting
5 Chapter 5: Prescription Validity, Prescriber Authority & Opioid Limits
5.1 Elements of a Valid Massachusetts Prescription 5.2 Prescriber Authority & the Massachusetts Controlled Substances Registration 5.3 The Massachusetts Electronic Prescribing Mandate 5.4 M.G.L. c. 94C, Massachusetts Schedules & Prescription Validity Windows 5.5 Opioid Prescribing Limits & Partial Fill Rights
6 Chapter 6: Refills, Transfers, Recordkeeping & Emergency Dispensing
6.1 Refill Limits, Sequential Schedule II Prescriptions & Partial Fills 6.2 Prescription Transfers & Pharmacy Recordkeeping 6.3 Out-of-State Prescriptions 6.4 Emergency Dispensing: Oral Schedule II Orders & Schedule VI Emergency Supplies
7 Chapter 7: Product Selection, Labeling & Patient Care Standards
7.1 Mandatory Interchange & the Massachusetts List of Interchangeable Drug Products 7.2 Container Labeling, MedGuides & Patient Package Inserts 7.3 Patient Counseling, Profiles & Drug Utilization Review 7.4 Pharmacist Administration of Drugs & Vaccines 7.5 Returning, Reusing & Disposing of Dispensed Drugs
8 Chapter 8: MassPAT, Nonprescription Products, Public Health & Privacy
8.1 MassPAT: Prescription Monitoring Program Query & Reporting 8.2 Naloxone, Syringes & Standing Orders 8.3 Patient Privacy (HIPAA) & Massachusetts Privacy Rules 8.4 Nonprescription, Behind-the-Counter & Restricted OTC Products
9 Chapter 9: Pharmacy Facilities, Security, Automation & Quality
9.1 Pharmacy Licensure, Facilities & Required References 9.2 Continuous Quality Improvement & Quality Related Events 9.3 Pharmacy Practice Automation & Automated Dispensing Devices 9.4 Security, Delivery, Central Fill & Non-Resident Practice
10 Chapter 10: Compounding, Hazardous Drugs & Expanded Pharmacist Practice
10.1 Non-Sterile Compounding: USP <795> & the Massachusetts Overlay 10.2 Sterile Compounding: USP <797> & the Massachusetts Overlay 10.3 Hazardous Drugs & USP <800> 10.4 Collaborative Drug Therapy Management
11 Chapter 11: The MPJE Blueprint, Delivery & Scoring
11.1 How the MPJE Is Built, Delivered and Scored
8.4 Nonprescription, Behind-the-Counter & Restricted OTC Products
Key Takeaways Explain This Topic AI
A nonprescription drug must bear adequate directions for use for a lay user; a drug whose labelling cannot achieve that is a prescription drug under the Durham-Humphrey Amendment.
The federal Combat Methamphetamine Epidemic Act limits pseudoephedrine, ephedrine and phenylpropanolamine to 3.6 g per purchaser per day and 9 g per 30 days, with behind-the-counter placement, photo identification and a logbook retained two years.
Schedule V narcotic-containing preparations may be sold without a prescription only where state law permits, only by a pharmacist, only to a purchaser at least 18 years old with identification, and only in limited quantities recorded in a bound book.
Massachusetts Schedule VI means a nonprescription-looking product that is legend under federal or state law is still a controlled substance for state purposes.
The exemption of an OTC product from child-resistant packaging is decided product by product under the Poison Prevention Packaging Act, not by prescription status.
Last updated: August 2026
Nonprescription, Behind-the-Counter & Restricted OTC Products
The NABP blueprint devotes a whole sub-area to the distribution and dispensing of nonprescription pharmaceutical products, including controlled substances and hazardous drugs . It is the part of the counter candidates study least and the part where the rules are most specific.
What Makes a Drug Nonprescription
The Durham-Humphrey Amendment of 1951 created the split. A drug is a prescription (legend) drug where it is habit-forming, toxic or has potential for harm, or where its method of use requires the supervision of a practitioner. Everything else may be over the counter , provided its labelling bears adequate directions for use that a lay person can follow.
The two labelling standards mirror each other:
Product Required labelling
Nonprescription drug Adequate directions for use — the Drug Facts panel: active ingredients, uses, warnings, directions, other information, inactive ingredients
Prescription drug Adequate information for use directed at practitioners — the package insert; the container bears "Rx only"
A nonprescription product whose label does not bear adequate directions for use is misbranded .
Important
Massachusetts Schedule VI catches the edge cases. Because Schedule VI captures every drug that may be dispensed only on a prescription and is not federally scheduled, a product that is prescription-only in Massachusetts is a state controlled substance even if it looks unremarkable. Conversely, a genuinely over-the-counter product is not in Schedule VI at all.
Behind-the-Counter: Methamphetamine Precursors
The Combat Methamphetamine Epidemic Act of 2005 (CMEA) put pseudoephedrine, ephedrine and phenylpropanolamine behind the counter nationwide without making them prescription drugs. The controls are quantitative and testable:
- Control Requirement
- Placement Behind the counter or in a locked cabinet
- Daily limit 3.6 g of base product per purchaser per day
- 30-day limit 9 g per purchaser per 30 days (7.5 g for mail order)
- Identification Government-issued photo identification
- Logbook Purchaser name, address, product, quantity, date and time of sale, and signature
- Record retention Two years
Staff Sale by a pharmacist or a trained employee under the pharmacist's supervision; the pharmacy must self-certify staff training
Electronic tracking systems record sales in real time and can block a transaction that would exceed a threshold. A refusal generated by the tracking system is not discretionary — the sale may not proceed.
Nonprescription Sale of Schedule V Narcotic Preparations
Federal law permits certain Schedule V preparations containing limited quantities of a narcotic — classically codeine-containing antitussives — to be sold without a prescription , but only under tight conditions and only where state law permits :
the sale is made by a pharmacist (the pharmacist may not delegate the actual transaction, though a non-pharmacist may complete the payment once the pharmacist has handed the product over);
the purchaser is at least 18 years old and produces identification if not known to the pharmacist;
the quantity is limited — not more than 240 mL or 48 dosage units of a product containing opium, and not more than 120 mL or 24 dosage units of any other Schedule V controlled substance, to the same purchaser in any 48-hour period ;
the pharmacist records the sale in a bound record book showing the purchaser's name and address, the product, the quantity, the date and the dispenser's name or initials; and
the book is retained for two years .
Caution
State law is the gatekeeper. The federal provision is permissive, not mandatory: it allows nonprescription Schedule V sales where not prohibited by state law . Massachusetts places every prescription-only drug in Schedule VI and regulates controlled substances tightly under c. 94C, so a pharmacist should confirm the Massachusetts position for the specific product rather than relying on the federal permission alone.
Naloxone and Syringes
The two most consequential Massachusetts nonprescription-access provisions are covered in section 8.2: naloxone under the standing order authority connected with M.G.L. c. 94C, § 19B , and hypodermic syringes and needles under M.G.L. c. 94C, § 27 . Both are examples of the Commonwealth deliberately removing a prescription barrier for a public-health purpose, and both carry counselling expectations rather than sales restrictions.
Packaging of Nonprescription Products
The Poison Prevention Packaging Act reaches OTC products as well as prescription drugs, and the analysis is product by product , not category by category. Familiar OTC child-resistant requirements include:
- aspirin and acetaminophen in specified presentations;
- ibuprofen above defined thresholds;
- iron-containing products above defined elemental-iron thresholds;
imidazoline eye and nose drops above defined quantities.
OTC products may be sold in non-child-resistant packaging where the manufacturer supplies a single size in that form and a child-resistant size is also marketed. The waiver structure that applies to prescriptions — a patient may give a blanket waiver, a prescriber may waive only prescription by prescription — is a prescription concept and does not transfer to shelf sales.
Worked Traps
A customer buys 2.4 g of pseudoephedrine base in the morning and returns at teatime for another 1.8 g. Refuse — the combined 4.2 g exceeds the 3.6 g daily limit.
A technician completes the sale of a codeine-containing Schedule V antitussive without a prescription while the pharmacist verifies elsewhere. Violation — the nonprescription Schedule V sale must be made by the pharmacist.
A pharmacy keeps CMEA logbook entries for one year. Violation — two years.
A 17-year-old asks to buy a nonprescription codeine cough preparation. Refuse — the purchaser must be at least 18.